The Pune-based Serum Institute of India has already begun manufacturing the Oxford vaccine (ChAdOx1 nCoV-19) for novel coronavirus.
The company will begin manufacturing vaccines of such quantity that meets the requirements of a commercial-scale batch for the phase-3 trial of the vaccine. The number of doses manufactured per commercial-scale batch would depend on whether the vials will be a single- or multi-dose.
While phase-3 trials have begun in the UK, Brazil (June 20), and South Africa (first week of July), Serum Institute will soon be seeking permission to carry out a multicentric phase-3 trial in India. The trial will recruit a few thousand participants.
Qantas Airways Ltd's last Boeing 747 jet began its final flight to retirement in the Mojave Desert on Wednesday, ending the model's almost half a century of service at the carrier.
Qantas 747s carried more than 250 million people in almost half a century of service, including Queen Elizabeth II and every Australian Olympic team since 1984. Qantas was once the world's only airline with an all 747 fleet.
The four-engine plane with less favourable economics than newer-generation 787s and Airbus SE A350s had fallen out of favour even before the coronavirus pandemic but Qantas, British Airways, Virgin Atlantic and KLM have hastened retirement plans due to the lack of international travel demand.